Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 120 EUR -0.7%
Market Cap: 52.2B EUR

MRK's latest stock split occurred on Jun 30, 2014

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, MRK traded at 128.35 per share. Afterward, the share price was about 56.1599.

The adjusted shares began trading on Jun 30, 2014. This was MRK's 2nd stock split, following the previous one in Jan 24, 2007.

Last Splits:
Jun 30, 2014
2-for-1
Jan 24, 2007
1367-for-1346
Pre-Split Price
56.8553 128.35
Post-Split Price
56.1599
Before
After
Last Splits:
Jun 30, 2014
2-for-1
Jan 24, 2007
1367-for-1346

Merck KGaA
Stock Splits History

MRK Stock Splits Timeline
Jun 30, 2014
Jun 30, 2014
Split 2-for-1
x2
Pre-Split Price
56.8553 128.35
Post-Split Price
56.1599
Before
After
Jan 24, 2007
Jan 24, 2007
Split 1367-for-1346
x1.0156017830609
Pre-Split Price
N/A
Post-Split Price
32.3446
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
47.5 47.5 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
60.6 60.6 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

Merck KGaA
Glance View

In the heart of Darmstadt, Germany, Merck KGaA stands as a testament to innovation and resilience, tracing its roots back to 1668. A bastion of scientific advancement and a pioneer in the world of chemistry and pharmaceuticals, Merck has evolved through centuries of discovery and transformation. Originally a humble pharmacy, Merck has grown into a global powerhouse with a unique structure, being one of the oldest pharmaceutical and chemical companies in the world still owned by the founding family. Though its path has been influenced by numerous historical events, Merck has adeptly navigated the shifting sands of time, transforming itself into a multifaceted conglomerate that thrives on its dual strategy—life sciences and performance materials. In the modern age, Merck KGaA operates through three well-defined sectors: Healthcare, Life Science, and Electronics. Its Healthcare division plays a formidable role, developing innovative drugs, with a focus on oncology, neurology, and immunology, providing cutting-edge treatments that improve patient lives globally. Meanwhile, the Life Science arm caters to researchers and scientists, offering an extensive portfolio of lab materials, high-tech tools, and equipment essential for groundbreaking research across various industries. The Electronics division, dedicated to performance materials, supplies high-quality substances crucial for the electronics and automotive industries, including liquid crystals and highly sophisticated semiconductor solutions. Through these divisions, Merck KGaA not only generates substantial revenue but also drives progress by supplying critical products that are indispensable to the modern technological landscape.

MRK Intrinsic Value
HIDDEN
Show
Back to Top